Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMMAD H KABIR

Allopathic & Osteopathic Physicians Internal Medicine Addiction Medicine

NPI
1326131715
CMS profile
287366
Location
TROY, NY

General Payments · PY2018–2024

$20,387.98

  • Reported across 158 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,388.62

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,388.62 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $708.78 6
GlaxoSmithKline, LLC. $349.48 3
ABBVIE INC. $331.39 3
Braeburn Inc. $254.32 15
ABIOMED $141.91 1
Supernus Pharmaceuticals, Inc. $122.88 1
Lilly USA, LLC $121.84 1
Boehringer Ingelheim Pharmaceuticals, Inc. $115.52 1
Vanda Pharmaceuticals Inc. $112.56 1
Sumitomo Pharma America, Inc. $107.46 1
Indivior Inc. $22.48 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,848.14 40
PY2019 $7,908.92 46
PY2020 $246.62 3
PY2021 $501.80 7
PY2022 $327.62 8
PY2023 $1,166.26 20
PY2024 $2,388.62 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $125.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104017110 CMS
ABBVIE INC. $88.34 08/27/2024 Food and Beverage Undisputed 01/23/2026 1104017112 CMS
ABBVIE INC. $118.05 09/11/2024 Food and Beverage Undisputed 01/23/2026 1104017114 CMS
ABIOMED $141.91 06/06/2024 Food and Beverage Undisputed 01/23/2026 1142280219 CMS
AstraZeneca Pharmaceuticals LP $104.96 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104327046 CMS
AstraZeneca Pharmaceuticals LP $125.00 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104243025 CMS
AstraZeneca Pharmaceuticals LP $115.20 03/14/2024 Food and Beverage Undisputed 01/23/2026 1104302464 CMS
AstraZeneca Pharmaceuticals LP $121.84 09/12/2024 Food and Beverage Undisputed 01/23/2026 1105802847 CMS
AstraZeneca Pharmaceuticals LP $125.06 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104654293 CMS
AstraZeneca Pharmaceuticals LP $116.72 10/02/2024 Food and Beverage Undisputed 01/23/2026 1105723755 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $115.52 06/27/2024 Food and Beverage Undisputed 01/23/2026 1117964385 CMS
Braeburn Inc. $3.44 01/23/2024 Food and Beverage Undisputed 01/23/2026 1125605499 CMS
Braeburn Inc. $7.55 02/27/2024 Food and Beverage Undisputed 01/23/2026 1125605483 CMS
Braeburn Inc. $4.48 03/11/2024 Food and Beverage Undisputed 01/23/2026 1125605485 CMS
Braeburn Inc. $12.55 04/01/2024 Food and Beverage Undisputed 01/23/2026 1125605481 CMS
Braeburn Inc. $15.89 04/04/2024 Food and Beverage Undisputed 01/23/2026 1125605479 CMS
Braeburn Inc. $3.99 04/08/2024 Food and Beverage Undisputed 01/23/2026 1125605487 CMS
Braeburn Inc. $20.72 04/23/2024 Food and Beverage Undisputed 01/23/2026 1125605489 CMS
Braeburn Inc. $3.25 05/08/2024 Food and Beverage Undisputed 01/23/2026 1125605491 CMS
Braeburn Inc. $4.16 06/26/2024 Food and Beverage Undisputed 01/23/2026 1125605493 CMS
Braeburn Inc. $122.88 07/18/2024 Food and Beverage Undisputed 01/23/2026 1125605507 CMS
Braeburn Inc. $14.37 07/25/2024 Food and Beverage Undisputed 01/23/2026 1125605497 CMS
Braeburn Inc. $8.90 07/31/2024 Food and Beverage Undisputed 01/23/2026 1125605495 CMS
Braeburn Inc. $9.68 08/30/2024 Food and Beverage Undisputed 01/23/2026 1125605505 CMS
Braeburn Inc. $20.33 09/18/2024 Food and Beverage Undisputed 01/23/2026 1125605501 CMS
Braeburn Inc. $2.13 11/07/2024 Food and Beverage Undisputed 01/23/2026 1125605503 CMS
GlaxoSmithKline, LLC. $113.11 03/21/2024 Food and Beverage Undisputed 01/23/2026 1116492285 CMS
GlaxoSmithKline, LLC. $121.60 08/21/2024 Food and Beverage Undisputed 01/23/2026 1116441935 CMS
GlaxoSmithKline, LLC. $114.77 11/13/2024 Food and Beverage Undisputed 01/23/2026 1115794221 CMS
Indivior Inc. $22.48 02/21/2024 Food and Beverage Undisputed 01/23/2026 1144530862 CMS
Lilly USA, LLC $121.84 10/10/2024 Food and Beverage Undisputed 01/23/2026 1135254334 CMS
Sumitomo Pharma America, Inc. $107.46 10/17/2024 Food and Beverage Undisputed 01/23/2026 1148870991 CMS
Supernus Pharmaceuticals, Inc. $122.88 10/15/2024 Food and Beverage Undisputed 01/23/2026 1147889477 CMS
Vanda Pharmaceuticals Inc. $112.56 08/22/2024 Food and Beverage Undisputed 01/23/2026 1133908093 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.